PHARMACOKINETIC CONSIDERATIONS ON RESISTANCE TO ANTICANCER DRUGS

被引：0
|
作者：
DEDRICK, RL
ZAHARKO, DS
BENDER, RA
BLEYER, WA
LUTZ, RJ
机构：
[1] NIH, DIV RES SERV,BIOMED ENGN & INSTRUMENTATION BRANCH, BLDG 13,ROOM 3W13, BETHESDA, MD 20014 USA
[2] NCI, DIV CANC TREATMENT, PHARMACOKINETICS & PHARMACODYN SECT, LAB CHEM PHARMACOL, BETHESDA, MD USA
[3] UNIV WASHINGTON, CHILDRENS ORTHOPEDIC HOSP, DEPT PEDIAT, DIV HEMATOL ONCOL, SEATTLE, WA USA
[4] NCI, DIV CANC TREATMENT, MED BRANCH, BETHESDA, MD USA
来源：
CANCER CHEMOTHERAPY REPORTS PART 1 | 1975年 / 59卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：795 / 804
页数：10
相关论文
共 50 条
  • [21] Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development
    Wang, Lingzhi
    Do Dang Khoa Phan
    Zhang, Jingwen
    Ong, Pei-Shi
    Thuya, Win Lwin
    Soo, R. A.
    Wong, Andrea Li-Ann
    Yong, Wei Peng
    Lee, Soo Chin
    Ho, Paul Chi-Lui
    Sethi, Gautam
    Goh, Boon Cher
    ONCOTARGET, 2016, 7 (28) : 44790 - 44802
  • [22] Anticancer drugs inducing insulin resistance
    Bouillet, B.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2024, 28 (04):
  • [23] Pseudo-resistance to anticancer drugs
    Davoli, Enrico
    Zucchetti, Massimo
    Giavazzi, Raffaella
    Garattini, Silvio
    Frapolli, Roberta
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [24] Overcoming Resistance to Targeted Anticancer Drugs
    Doroshow, James H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (19): : 1852 - 1853
  • [25] MULTIDRUG-RESISTANCE TO ANTICANCER DRUGS
    ROBERT, J
    BULLETIN DU CANCER, 1994, 81 : S33 - S38
  • [26] DRUGS IN HUMAN-MILK - CLINICAL PHARMACOKINETIC CONSIDERATIONS
    ATKINSON, HC
    BEGG, EJ
    DARLOW, BA
    CLINICAL PHARMACOKINETICS, 1988, 14 (04) : 217 - 240
  • [27] TESTING FOR DRUGS OF ABUSE - PHARMACOKINETIC CONSIDERATIONS FOR COCAINE IN URINE
    OSTERLOH, J
    CLINICAL PHARMACOKINETICS, 1993, 24 (05) : 355 - 361
  • [28] HEPATIC-CLEARANCE OF DRUGS PHYSIOLOGICAL AND PHARMACOKINETIC CONSIDERATIONS
    PELLEGRIN, PL
    LESNE, M
    JOURNAL DE PHARMACOLOGIE, 1983, 14 (02) : 107 - 139
  • [29] THE SIGNIFICANCE OF DRUGS IN BREAST-MILK - PHARMACOKINETIC CONSIDERATIONS
    RIVERACALIMLIM, L
    CLINICS IN PERINATOLOGY, 1987, 14 (01) : 51 - 70
  • [30] Pharmacokinetic interactions between antiepileptic drugs - Clinical considerations
    Riva, R
    Albani, F
    Contin, M
    Baruzzi, A
    CLINICAL PHARMACOKINETICS, 1996, 31 (06) : 470 - 493
12345